Company profile: Bruker
1.1 - Company Overview
Company description
- Provider of analytical and medical instruments covering NMR, ESR, FT-IR and X-ray spectroscopy. MALDI Imaging to visualize molecular distribution in tissue sections; neofleX MALDI-TOF/TOF benchtop MS for protein and peptide analysis; Q6 NEWTON optical emission spectrometer for precise metal and alloy composition; BEAM FT-NIR for real-time process control of solid and semi-solid materials; and Dektak Pro profilometer for semiconductor surfaces.
Products and services
- NeofleX MALDI-TOF/TOF: A benchtop mass spectrometer combining fast analysis speed with ease of operation for protein and peptide analysis across a wide application range
- MALDI Imaging: A mass-spectrometry-based technique that visualizes the spatial distribution of molecules in tissue sections to aid understanding of complex biological systems
- Q6 NEWTON: A high-precision optical emission spectrometer engineered for reliable metal analysis, determining alloy compositions with reproducible accuracy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bruker
Newomics
HQ: United States
Website
- Description: Provider of integrative platforms for personalized healthcare, offering mass spectrometry and LC-MS solutions including DuoESI Source (dual ion source enhancing ionization for multiomics, compatible with leading mass spectrometers), MEA Chip (silicon LC column/ESI emitter/post-column inlet chip for improved sensitivity and robustness in proteomics), and M3 Emitter (silicon microfluidic flow-splitting emitter for enhanced ionization).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newomics company profile →
Miromatrix
HQ: United States
Website
- Description: Provider of fully biological human organs and organ-derived products to address the transplant shortage, using patented perfusion decellularization/recellularization technology, plus PAH therapy and patient support via Remodulin (IV/SC), ASSIST, Archways for inhaled/oral treprostinil, and an Expanded Access Program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Miromatrix company profile →
Microbiome Insights
HQ: Canada
Website
- Description: Provider of end-to-end microbiome DNA sequencing services and state-of-the-art bioinformatic analysis. Offerings include 16S V4 amplicon sequencing for taxonomic profiling, shotgun metagenomic sequencing for species-level and functional insights, short-chain fatty acid analysis in stool, qPCR for absolute abundance, and comprehensive bioinformatics processing and reporting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microbiome Insights company profile →
Delphi Genetics
HQ: Belgium
Website
- Description: Provider of plasmid DNA and genetic engineering services, developing customized GMP plasmid DNA manufacturing solutions to support viral and non-viral gene therapy programs, based on unique technologies including patented STABY® technology without antibiotic resistance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Delphi Genetics company profile →
C-Lecta
HQ: Germany
Website
- Description: Provider of enzyme engineering and bioprocess development for regulated markets, developing, manufacturing, and commercializing application-oriented enzyme variants. Offers the ENESYZ technology platform for customized enzymes and microbial production strains, enzymes for food and pharmaceutical industries, and biocatalytic products that replace complex chemical processes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full C-Lecta company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bruker
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bruker
2.2 - Growth funds investing in similar companies to Bruker
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bruker
4.2 - Public trading comparable groups for Bruker
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →